Occupational trichloroethylene exposure and antinuclear antibodies: a cross-sectional study in China.


Journal

Occupational and environmental medicine
ISSN: 1470-7926
Titre abrégé: Occup Environ Med
Pays: England
ID NLM: 9422759

Informations de publication

Date de publication:
10 2022
Historique:
received: 02 02 2022
accepted: 16 04 2022
pubmed: 4 5 2022
medline: 17 9 2022
entrez: 3 5 2022
Statut: ppublish

Résumé

There has been concern over the possible risk of autoimmune diseases from exposure to trichloroethylene (TCE), an industrial solvent and common pollutant near hazardous waste sites. Studies of TCE-exposed lupus-prone mouse strains have reported increases in serum antinuclear antibodies (ANAs), a marker of autoimmunity, and autoimmune pathologic changes, while epidemiologic studies have provided limited support for an association between TCE exposure and scleroderma. To investigate exposure-related biologic evidence of autoimmunity in humans, we measured ANA levels in sera from a cross-sectional study of TCE-exposed (n=80) and TCE-unexposed (n=96) workers in Guangdong, China. Full-shift personal air exposure measurements for TCE were taken prior to blood collection. Serum ANAs were detected by immunofluorescence on HEp-2 cells. We calculated ORs and 95% CI relating levels of TCE exposure (categorised using tertiles as cut-points) and ANA positivity (1+ intensity at 1:320 dilution) using multivariable logistic regression. Samples from 16 of 176 participants were ANA-positive. We found higher levels of TCE exposure (concentrations>17.27 ppm) to be associated with an elevated odds of ANA positivity (OR 4.7, 95% CI 1.3 to 16.8) compared with unexposed controls. This association remained after excluding two subjects with diagnosed autoimmune disease (OR 4.5, 95% CI 1.2 to 16.2). We did not observe an association with ANAs at lower exposure levels. Our findings, to our knowledge the first direct human evidence of an association between TCE exposure and systemic autoimmunity, provide biologic plausibility to epidemiologic evidence relating TCE and autoimmune disease.

Identifiants

pubmed: 35504721
pii: oemed-2022-108266
doi: 10.1136/oemed-2022-108266
pmc: PMC10187559
mid: NIHMS1802033
doi:

Substances chimiques

Antibodies, Antinuclear 0
Biological Products 0
Trichloroethylene 290YE8AR51

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

717-720

Subventions

Organisme : Intramural NIH HHS
ID : Z99 CA999999
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Occup Environ Med. 2002 Aug;59(8):545-9
pubmed: 12151611
Arthritis Rheum. 2012 Jul;64(7):2319-27
pubmed: 22237992
Environ Health Perspect. 2009 May;117(5):696-702
pubmed: 19479009
Autoimmun Rev. 2003 May;2(3):119-25
pubmed: 12848952
Arthritis Rheum. 1998 Jun;41(6):1111-8
pubmed: 9627022
Carcinogenesis. 2010 Sep;31(9):1592-6
pubmed: 20530238
Mod Rheumatol. 2009;19(3):219-28
pubmed: 19277826
Curr Ther Res Clin Exp. 2014 Nov 26;76:116-9
pubmed: 25473438
Arthritis Rheumatol. 2020 Jun;72(6):1026-1035
pubmed: 32266792
N Engl J Med. 2003 Oct 16;349(16):1526-33
pubmed: 14561795
Am J Epidemiol. 2003 Mar 15;157(6):493-500
pubmed: 12631538
Arthritis Rheumatol. 2016 Oct;68(10):2492-502
pubmed: 27059145
Reumatol Clin. 2017 May - Jun;13(3):150-155
pubmed: 27221374
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462

Auteurs

Mark Purdue (M)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA purduem@mail.nih.gov.

Luoping Zhang (L)

School of Public Health, University of California Berkeley, Berkeley, California, USA.

Roel Vermeulen (R)

Institute for Risk Assessment Sciences, Utrecht University, Utrecht, The Netherlands.

Martyn T Smith (MT)

School of Public Health, University of California Berkeley, Berkeley, California, USA.

Wei Hu (W)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Jongeun Rhee (J)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Cuiju Wen (C)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, China.

Yongshun Huang (Y)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, China.

Xiaojiang Tang (X)

Guangdong Province Hospital for Occupational Disease Prevention and Treatment, Guangzhou, Guangdong, China.
Zhuhau BesTest Biotechnology Co. Ltd, Zhuhai, Guangdong, China.

Sonja I Berndt (SI)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Ashley A Frazer-Abel (AA)

Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.

Kevin D Deane (KD)

Department of Medicine, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.

Nathaniel Rothman (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Qing Lan (Q)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH